Nothing Special   »   [go: up one dir, main page]

MX340185B - Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca. - Google Patents

Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca.

Info

Publication number
MX340185B
MX340185B MX2013002381A MX2013002381A MX340185B MX 340185 B MX340185 B MX 340185B MX 2013002381 A MX2013002381 A MX 2013002381A MX 2013002381 A MX2013002381 A MX 2013002381A MX 340185 B MX340185 B MX 340185B
Authority
MX
Mexico
Prior art keywords
bone marrow
precursor cells
marrow derived
cardiac repair
repair
Prior art date
Application number
MX2013002381A
Other languages
English (en)
Other versions
MX2013002381A (es
Inventor
M Hare Joshua
K Mcniece Ian
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Publication of MX2013002381A publication Critical patent/MX2013002381A/es
Publication of MX340185B publication Critical patent/MX340185B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La presente invención se refiere a una cantidad terapéuticamente efectiva de células precursoras de células madre mesenquimales (MSC) CD271+aisladas que se aíslan de la médula ósea de un sujeto y se cultivan bajo condiciones no adherentes para uso en la prevención o tratamiento de enfermedades o trastornos cardiovasculares, en tanto las células precursora de MSC CD271+son capaces de injertarse en un corazón en vivo en la zonas infartadas y de frontera.
MX2013002381A 2010-08-27 2011-08-29 Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca. MX340185B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37766110P 2010-08-27 2010-08-27
PCT/US2011/049542 WO2012027740A1 (en) 2010-08-27 2011-08-29 Bone marrow derived cd271 precursor cells for cardiac repair

Publications (2)

Publication Number Publication Date
MX2013002381A MX2013002381A (es) 2013-04-29
MX340185B true MX340185B (es) 2016-06-29

Family

ID=45723836

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013002381A MX340185B (es) 2010-08-27 2011-08-29 Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca.

Country Status (14)

Country Link
US (3) US20140023621A1 (es)
EP (1) EP2608797B1 (es)
JP (1) JP6061345B2 (es)
KR (1) KR101920891B1 (es)
CN (1) CN103221058B (es)
AU (1) AU2011293144B2 (es)
BR (1) BR112013004700B1 (es)
CA (1) CA2842181C (es)
ES (1) ES2556961T3 (es)
IL (1) IL224917A (es)
MX (1) MX340185B (es)
NZ (1) NZ608734A (es)
SG (1) SG188305A1 (es)
WO (1) WO2012027740A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2729562B1 (en) 2011-07-06 2018-04-18 Cell Therapy Limited Progenitor cells of mesodermal lineage
JP6090735B2 (ja) * 2012-03-02 2017-03-08 国立大学法人山口大学 消化器系がん幹細胞を培養するための無血清培地、及びそれを用いた消化器系がん幹細胞の増殖方法
WO2013163539A1 (en) * 2012-04-26 2013-10-31 The Cohen Mcniece Foundation Human fetal heart derived stromal cells for treatment of patients following a myocardial infarction
US10071123B2 (en) 2012-08-01 2018-09-11 United Therapeutics Corporation Treatment of pulmonary arterial hypertension with mesenchymal stem cells
JP6746313B2 (ja) 2012-08-01 2020-08-26 ユナイテッド セラピューティクス コーポレイション プロスタサイクリン処理された内皮前駆細胞による肺動脈性高血圧症の処置
KR102466885B1 (ko) * 2013-01-09 2022-11-11 유나이티드 세러퓨틱스 코오포레이션 프로스타시클린 및 중간엽 줄기 세포를 사용한 혈관병증의 치료
US10456943B2 (en) * 2014-12-03 2019-10-29 Urschel Laboratories, Inc. Machines and methods for cutting products and impellers therefor
EP4249056A3 (en) * 2014-12-23 2023-10-18 Mesoblast International Sàrl Method for treating heart failure
US11491188B2 (en) * 2014-12-23 2022-11-08 Mesoblast International Sarl Prevention of progressive heart failure
JP6777840B2 (ja) * 2015-12-25 2020-10-28 北海道公立大学法人 札幌医科大学 脳梗塞の治療用医薬
CN106474456A (zh) * 2016-10-18 2017-03-08 广州赛莱拉干细胞科技股份有限公司 一种细胞制剂及其制备方法和应用
IL266175B2 (en) 2016-10-24 2024-01-01 United Therapeutics Corp Enhancement of immunomodulatory properties of MSC using treprostinil
EP3856203A4 (en) * 2018-09-27 2022-02-23 Biocardia, Inc. BONE MARROW DERIVED NEUROKININ 1 RECEPTOR POSITIVE (NK1R+) PROGENIOR CELLS FOR THERAPEUTIC APPLICATIONS
CN110302212A (zh) * 2019-07-17 2019-10-08 陶正博 一种用于治疗急性心肌梗死的细胞制剂及其制备方法
CA3151637A1 (en) * 2019-08-28 2021-03-04 Astellas Institute For Regenerative Medicine Methods of treating vascular diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009060840A (ja) * 2007-09-06 2009-03-26 Keio Gijuku ヒト間葉系幹細胞濃縮方法
WO2009140452A2 (en) * 2008-05-15 2009-11-19 University Of Miami Isolation of stem cell precursors and expansion in non-adherent conditions
US20110305673A1 (en) * 2008-11-12 2011-12-15 The University Of Vermont And State Agriculture College Compositions and methods for tissue repair

Also Published As

Publication number Publication date
US20180214486A1 (en) 2018-08-02
KR20130106381A (ko) 2013-09-27
EP2608797A1 (en) 2013-07-03
ES2556961T3 (es) 2016-01-21
AU2011293144B2 (en) 2015-04-23
EP2608797A4 (en) 2014-01-22
JP2013542178A (ja) 2013-11-21
CA2842181A1 (en) 2012-03-01
EP2608797B1 (en) 2015-09-23
KR101920891B1 (ko) 2018-11-21
CN103221058A (zh) 2013-07-24
AU2011293144A1 (en) 2013-04-18
NZ608734A (en) 2014-09-26
BR112013004700B1 (pt) 2020-12-08
WO2012027740A1 (en) 2012-03-01
CA2842181C (en) 2021-01-05
US20230071551A1 (en) 2023-03-09
US20140023621A1 (en) 2014-01-23
BR112013004700A2 (pt) 2017-07-04
JP6061345B2 (ja) 2017-01-18
SG188305A1 (en) 2013-04-30
MX2013002381A (es) 2013-04-29
CN103221058B (zh) 2015-07-29
IL224917A (en) 2017-02-28

Similar Documents

Publication Publication Date Title
MX340185B (es) Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca.
MX2010003019A (es) Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
EP2294183A4 (en) MESENCHYMAL STEM CELLS, COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIAC TISSUE LESIONS
WO2011002239A3 (ko) 포유류의 유핵세포에서 유래된 마이크로베시클 및 이의 용도
NZ612455A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
WO2012071526A3 (en) Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
NZ591293A (en) Methods and compositions for treatment of bone defects with osteogenic placental adherent cells (OPACs)
EP2593117A4 (en) BIOKOMPATIBLE SUBSTRATE FOR PROMOTING NETWORKING BETWEEN STEM CELLS AND TARGET TISSUE AND PROCESS FOR ITS IMPLANTATION
MX2010005018A (es) Tratamiento de complicaciones de nacimiento prematuro.
MX2009004238A (es) Metodos y composiciones para tratamiento de defectos oseos con poblaciones de celulas de placenta.
NZ623454A (en) Pharmaceutical composition for the treatment of heart diseases
NZ603376A (en) Smooth muscle cell constructs
WO2006127007A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
MX2010001353A (es) Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
NZ595331A (en) Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
EP2861238A4 (en) OPTIMIZED METHODS FOR GENERATING CARDIAC STEM CELLS FROM CARDIAC TISSUE AND THEIR USE IN CARDIAC THERAPY
WO2012047951A3 (en) Human lung stem cells and uses thereof
WO2009114703A3 (en) Combination therapy for the treatment of cancer
WO2011151815A3 (en) Implant with body and at least one flute
EP3959304A4 (en) GENERATION OF FUNCTIONAL AND PATIENT-SPECIFIC THYMIC TISSUE IN VIVO FROM INDUCED PLURIPOTENT STEM CELLS
WO2011118954A3 (ko) 사람 하비갑개 유래 중간엽 기질세포로부터 연골, 골, 신경세포 또는 지방세포를 분화시키는 방법
NZ595440A (en) Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
WO2013055889A3 (en) Implantable scaffolds and methods of use
SG11201900986YA (en) Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
Kohara et al. Tissue engineering technology to enhance cell recruitment for regeneration therapy

Legal Events

Date Code Title Description
FG Grant or registration